Presentation Association of Depression With Mortality in Older Adults Undergoing TAVR or SAVR January 18, 2018
Presentation TCT 2017 TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials Presenter: Steven R. Bailey, Patrick W. Serruys, Angelo Biviano, MD November 01, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 TAVR vs SAVR: What Do the 2017 ESC Guidelines Say? Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian October 29, 2017
Presentation TVT 2017 A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability Presenter: Martin B. Leon, Hendrik Treede June 16, 2017
Presentation TVT 2017 A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors Presenter: David J. Cohen, Jeffrey J. Popma, Martin B. Leon June 16, 2017
Presentation TVT 2017 The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR) Presenter: A. Pieter Kappetein June 16, 2017
Presentation TVT 2017 The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection Presenter: Axel Linke, Jeffrey J. Popma, Samir R. Kapadia June 15, 2017
Presentation TVT 2017 A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack June 15, 2017
Presentation TVT 2017 The Compelling Saga of Strokes After TAVR (and SAVR): Diagnosis Considerations and Key Messages From NeuroARC Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem June 15, 2017
Presentation SWVS 2017 Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF Presenter: Ankur Kalra May 06, 2017
Presentation ACC 2017 Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Michael Mack March 20, 2017
Presentation Miami Valves 2017 Should We Worry About Transcatheter Heart Valve Durability? Presenter: Danny Dvir January 31, 2017
Presentation Miami Valves 2017 Percutaneous Closure of Ascending Aorta Pseudoaneurysm after SAVR with Four Vascular Plugs Presenter: Adrian Ebner January 29, 2017
Presentation TCT 2016 TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green October 31, 2016
Presentation TCT 2016 TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr. October 31, 2016
Presentation TCT 2016 TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron October 31, 2016
Presentation TCT 2016 TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey October 31, 2016
Presentation TCT 2016 Case #1. Post-SAVR Paravalvulular Leak Presenter: Eulogio J. Garcia, E. Murat Tuzcu October 30, 2016